Drug Trial Radar · NCT06100523
PREVenting-ENvIronment-Reprotoxic Exposures Before In Vitro Fertilization (PREVENIR-FIV)
Last checked: Nov 19, 2026Latest source record: Oct 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
4,224
Planned (sponsor's estimate)
Start
Jan 2024
Primary completion
Jan 2026
Study completion Jun 2028
Sponsor
- Lead sponsor
- Assistance Publique Hopitaux De MarseilleAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 25, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective is to evaluate the effectiveness of an innovative personalized management strategy adapted to the level of environmental risk, in a population of infertile couples, eligible for assisted reproductive treatment (ART) by intraconjugal In Vitro Fertilization (IVF)/ Intracytoplasmic sperm injection (ICSI). Consultation of the couple at the ARTcenter : - Prescriptions of the standard assessment of infertility to the couples eligible for ART. - Inclusion and randomization (arm A interventional vs arm B standard management) of the couples having signed the consent. - Information for each patient on a standardized online self questionnaire on environmental exposures, physical activity and stress.
Conditions
- Infertility
Interventions
VisioconsulationBehavioral
Meeting by videoconsultation with professionals adapted to the exposures highlighted by the questionnaires for patients who responded on the dedicated application (Arm A)
self-assessment questionnaireBehavioral
self-administered questionnaire of assessment of reprotoxic exposures, assessment of stress, physical activity, quality of life in infertility course
hair samplingBiological
hair sampling from the 2 members of the couple
self-assessment questionnaire on dedicated applicationBehavioral
self-administered questionnaire of assessment of reprotoxic exposures, assessment of stress, physical activity, quality of life in infertility course
Specialized follow-upBehavioral
proactive healthcare pathway : active support of corrective measures implemented with couples by the platform, with the help of the application
self-assessment questionnaire for follow-upBehavioral
self-administered questionnaire of assessment of reprotoxic exposures, assessment of stress, physical activity, quality of life in infertility course
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical live birth rateTime frame: 24 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Assitance Publique Hôpitaux de Marseille
Marseille, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.